Insider · CIK 0001613867
Ali Behbahani
Files at CRSP (CRISPR Therapeutics AG), BDTX (Black Diamond Therapeutics, Inc.), KRRO (Korro Bio, Inc.), ACLX (Arcellx, Inc.), NKTX (Nkarta, Inc.), GLUE (Monte Rosa Therapeutics, Inc.). First filing Sep 21, 2026, latest Sep 21, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CRSP: CRISPR Therapeutics AG
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | CRISPR Therapeutics AG | $781k 13,679 shares | -45% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | BDTX Black Diamond Therapeutics, Inc. | AGrant or award Common Stock | +7,707 | $1.93 | $15k | 110,236 | 21 d ago |
| Sep 17, 2026 | CRSP CRISPR Therapeutics AG | MOption exercise Common Shares | +30,000 | $14.00 | $420k | 30,316 | 21 d ago |
| Aug 6, 2025 | CRSP CRISPR Therapeutics AG | JOther Common Shares | +60 | $0.00 | $0 | 316 | 21 d ago |
| Sep 17, 2026 | CRSP CRISPR Therapeutics AG | SOpen-market sale Common Shares | -13,679 | $57.09 | $781k | 16,637 | 21 d ago |
| Aug 6, 2025 | CRSP CRISPR Therapeutics AG | JOther Common Sharesindirect: See Note 3 | +15 | $0.00 | $0 | 29 | 21 d ago |
| Sep 17, 2026 | CRSP CRISPR Therapeutics AG | MOption exercise Stock Option (Right to Buy)derivative | -30,000 | $0.00 | $0 | 0 | 21 d ago |
| Jun 20, 2025 | BDTX Black Diamond Therapeutics, Inc. | AGrant or award Common Stock | +6,170 | $2.33 | $14k | 77,150 | Jun 20, 2025 |
| Jun 13, 2025 | GLUE Monte Rosa Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,700 | $0.00 | $0 | 30,700 | Jun 16, 2025 |
| Jun 12, 2025 | BDTX Black Diamond Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,550 | $0.00 | $0 | 30,550 | Jun 12, 2025 |
| Jun 11, 2025 | KRRO Korro Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +6,010 | $0.00 | $0 | 6,010 | Jun 12, 2025 |
| Jun 5, 2025 | NKTX Nkarta, Inc. | AGrant or award Stock Option (right to buy)derivative | +46,000 | $0.00 | $0 | 46,000 | Jun 9, 2025 |
| Jun 5, 2025 | CRSP CRISPR Therapeutics AG | AGrant or award Stock Option (Right to Buy)derivative | +13,000 | $0.00 | $0 | 13,000 | Jun 6, 2025 |
| May 29, 2025 | ACLX Arcellx, Inc. | AGrant or award Stock Option (right to buy)derivative | +9,174 | $0.00 | $0 | 9,174 | May 30, 2025 |
| Mar 21, 2025 | BDTX Black Diamond Therapeutics, Inc. | AGrant or award Common Stock | +7,646 | $1.88 | $14k | 70,980 | Mar 21, 2025 |
| Dec 13, 2024 | BDTX Black Diamond Therapeutics, Inc. | AGrant or award Common Stock | +5,750 | $2.50 | $14k | 63,334 | Dec 16, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.